Cargando…
Association of adenosine signaling gene signature with estrogen receptor-positive breast and prostate cancer bone metastasis
Bone metastasis is a common and devastating consequence of several major cancer types, including breast and prostate. Osteocytes are the predominant bone cell, and through connexin (Cx) 43 hemichannels release ATP to the bone microenvironment that can be hydrolyzed to adenosine. Here, we investigate...
Autores principales: | Shropshire, Daniel Brian, Acosta, Francisca M., Fang, Kun, Benavides, Jaime, Sun, Lu-Zhe, Jin, Victor X., Jiang, Jean X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520286/ https://www.ncbi.nlm.nih.gov/pubmed/36186774 http://dx.doi.org/10.3389/fmed.2022.965429 |
Ejemplares similares
-
Connexin 43 hemichannels protect bone loss during estrogen deficiency
por: Ma, Liang, et al.
Publicado: (2019) -
Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
por: Kim, Ryung S., et al.
Publicado: (2012) -
Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers
por: Chiu, Jen-Hwey, et al.
Publicado: (2017) -
Osteolytic effects of tumoral estrogen signaling in an estrogen receptor-positive breast cancer bone metastasis model
por: Cheng, Julia N., et al.
Publicado: (2021) -
The global status of research in prostate cancer bone metastasis: A bibliometric and visualized analysis
por: Lv, Zongwei, et al.
Publicado: (2022)